252 related articles for article (PubMed ID: 23702258)
1. A factor analytic study in bipolar depression, and response to lamotrigine.
Mitchell PB; Hadzi-Pavlovic D; Evoniuk G; Calabrese JR; Bowden CL
CNS Spectr; 2013 Aug; 18(4):214-24. PubMed ID: 23702258
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
3. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
[TBL] [Abstract][Full Text] [Related]
8. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
[TBL] [Abstract][Full Text] [Related]
10. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z
J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692
[TBL] [Abstract][Full Text] [Related]
12. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study.
Stamm TJ; Lewitzka U; Sauer C; Pilhatsch M; Smolka MN; Koeberle U; Adli M; Ricken R; Scherk H; Frye MA; Juckel G; Assion HJ; Gitlin M; Whybrow PC; Bauer M
J Clin Psychiatry; 2014 Feb; 75(2):162-8. PubMed ID: 24345793
[TBL] [Abstract][Full Text] [Related]
13. Melancholic Symptoms in Bipolar II Depression and Responsiveness to Lamotrigine in an Exploratory Pilot Study.
Peters EM; Bowen R; Balbuena L
J Clin Psychopharmacol; 2018 Oct; 38(5):509-512. PubMed ID: 30124585
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine: a depression mood stabiliser.
Herman E
Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613
[TBL] [Abstract][Full Text] [Related]
15. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
18. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
Heo M; Murphy CF; Meyers BS
Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
[TBL] [Abstract][Full Text] [Related]
20. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
